Hair Transplant Statistics 2026: Volumes, Results, Treatments

Surgeons performed 703,183 hair transplant procedures worldwide in 2021, a 152% rise since 2010, and counting nonsurgical care too, about 2.2 million people had a hair restoration treatment that year (ISHRS). The medications have hard numbers as well: in the pivotal 2-year trial, finasteride users had 138 more hairs than placebo in a one-inch test circle, and 5% minoxidil beat the 2% solution by 45% more regrowth in men.

This page collects the treatment numbers people search for: how many transplants happen each year, who gets them, and what randomized trials measured for finasteride, minoxidil and PRP. Every figure links to its source, and estimates are labelled as estimates.

How many hair transplants are performed each year?

The International Society of Hair Restoration Surgery (ISHRS) census counted 703,183 surgical hair restoration procedures worldwide in 2021. That was 4% below 2019, a pandemic-era dip, but 152% above 2010. For a longer view, the society counted 397,048 procedures in 2014, itself a 76% jump from 2006. Whatever the year-to-year wobble, the two-decade trend is steeply up.

Counting people instead of procedures, the same census estimated 2,221,191 patients worldwide had a hair restoration treatment in 2021: 628,604 surgical and 1,592,588 nonsurgical. Nonsurgical patient numbers grew 14% from 2019 while surgical patients dipped 8%, a hint that medication and other nonsurgical options are the wider funnel.

Census figure	2021	2024	Trend
Worldwide surgical procedures	703,183	not published	+152% vs 2010
Female share of procedures	12.7%	15.3%	rising
Grafts in a first session	2,176	2,347	up from 1,842 in 2010
Procedures to reach goal	~1.4	1.5	down from 5 in 2016
Members reporting black-market clinics in their city	51%	59%	rising
Average share of cases that are repairs	6%	10%	rising

Who gets hair transplants?

Younger people than the balding stereotype suggests. In the 2025 census (2024 data), over half of both male (58.7%) and female (54.0%) surgical patients were aged 30 to 49. Women are a growing share of the market: 15.3% of procedures in 2024, up from 12.7% in 2021. Procedures beyond the scalp are growing too: 18% of male procedures and 21% of female procedures were non-scalp in 2024, with eyebrow transplants making up 12% of women's procedures.

On motivation, 90% of surgeons said patients' top reason was to become or feel more attractive, and 63% cited appearing younger to compete at work. These are surgeon perceptions of patient motives, not a patient survey, so quote them with that label.

How successful are hair transplants?

The census tracks efficiency rather than a single success rate, and the efficiency numbers have moved fast. A first session now averages 2,347 grafts, up from 1,842 in 2010, and patients reach their desired result in about 1.5 procedures, down from 5 in 2016. Bigger sessions are part of why fewer sessions are needed; the same result that once took years of repeat surgery now typically takes one or two visits.

The census also tracks the field's dark side. In 2024, 59% of ISHRS members reported black-market transplant clinics in their cities, up from 51% in 2021, and repair work doubled to 10% of cases from 6%. Those numbers come from the surgeons who compete with those clinics, so the incentive cuts both ways, but the repair-rate trend is a concrete, countable warning: a growing share of legitimate surgeons' time now goes to fixing other clinics' work.

Behind the worldwide totals sits an ordinary working practice. In the 2024 data, the average ISHRS member performed about 178 hair restoration surgeries over the year, roughly 15 per month, and saw about 668 patients across surgical and nonsurgical care.

Does finasteride work? The trial statistics

The two established medications for pattern hair loss have unusually solid trial numbers, and they are worth quoting precisely because marketing rounds them into vaguer, kinder shapes.

The pivotal randomized trial (Kaufman et al., 1998) followed 1,553 men aged 18 to 41. In a standardized one-inch-diameter scalp circle, men on finasteride 1 mg had 107 more hairs than placebo at 1 year and 138 more at 2 years, while the placebo group progressively lost hair. A 5-year controlled extension reported durable improvement versus placebo on all endpoints.

The Endotext reference summarizes the broader literature: finasteride produces partial regrowth in about two thirds of men, and in a 10-year study 86% continued to benefit, with only 14% losing further ground. Mechanistically, the drug cuts scalp DHT by 64%. Worth knowing: the pivotal trial was industry-funded, as pivotal drug trials usually are; the numbers above are the published, peer-reviewed results.

Does minoxidil work? The trial statistics

In a 48-week randomized trial of 393 men (Olsen et al., 2002), the 5% solution produced 45% more regrowth than the 2% solution, with earlier response. A 2019 review quantifies the absolute effect: about 8 extra hairs per square centimetre for 2% minoxidil and about 15 for 5%, versus placebo. In women, a randomized trial (Lucky et al., 2004) found both strengths beat placebo on hair count, with 5% superior on patient-rated benefit at 48 weeks.

To make the trial units comparable: the finasteride result was counted in a one-inch-diameter circle, which covers about five square centimetres, so 138 extra hairs works out to roughly 27 extra hairs per square centimetre (our calculation from the published figures). That sits well above the 8 to 15 hairs per square centimetre the minoxidil literature reports, which matches the clinical consensus that finasteride is the stronger of the two for male pattern loss. Neither drug is a cure. The verified numbers are strong enough on their own: measured, repeatable differences against placebo, sustained for years.

Does PRP work for hair loss?

Platelet-rich plasma (PRP) injections moved from sports medicine to scalps with real, if noisy, results. A 2022 meta-analysis pooling 15 trials found average hair density rose from 141.9 to 177.5 hairs per square centimetre, a mean gain of 36.84 hairs per square centimetre. The authors flag substantial heterogeneity between trials, and an interesting pattern: younger patients responded better. PRP protocols are not standardized, which is the honest caveat behind the pooled number.

One more medication deserves a sentence, precisely because its numbers are missing. Dutasteride, a stronger relative of finasteride, has outperformed it in comparative trials according to the Endotext reference, but the openly accessible sources state no usable response percentages, so this page quotes none. A treatment can be promising while its headline numbers remain behind paywalls, and honest pages say so rather than borrowing figures they cannot check.

How big is the hair restoration market?

Two figures bracket the market's size. The ISHRS itself put the hair restoration market at 4.5 billion US dollars in 2021. Grand View Research, a market research firm, projected the global market to reach 13.6 billion by 2028, growing at 15.4% a year from 2021. The first is an association estimate; the second is a modelled projection from a firm that sells industry reports, quoted from its public press release. Both say the same simple thing: treating hair loss is a large and fast-growing business, which is exactly why unsourced statistics about it are everywhere.

How to read treatment claims

The verified numbers above give you a ruler for evaluating any hair loss treatment claim. Ask what was measured (hairs per square centimetre beats "improvement"), against what (placebo-controlled beats before-and-after photos), for how long (48 weeks is a minimum for hair), and who paid. A clinic's own success rate published on its own website fails the last test automatically, which is why none appear on this page.

Context pages worth pairing with this one: hair loss statistics for how common the underlying conditions are, hair growth statistics for the biology the treatments work against, and the thinning and hair loss styling guide for what a good cut can do while the medication does its slow work. And if you want to preview a shorter or restyled look before committing, Kurli's try-on renders it on your own photo.

Methodology and numbers we left out

Most figures on this page rest on the ISHRS Practice Census, a periodic survey of the society's member surgeons, weighted and extrapolated from per-surgeon averages to estimate the whole field with a stated margin around plus or minus 6%. It is self-reported by the industry's own professional body, which makes it the best available data and still worth reading with that origin in mind; medication numbers come from randomized controlled trials and PRP from a peer-reviewed meta-analysis. Three popular treatment statistics failed our sourcing bar and are deliberately absent: the finasteride responder trio ("83% kept their hair at 2 years, 66% regrew, 90% at 5 years") appears in countless articles but lives in paywalled full texts, as do glossier lines like "90% keep their hair", so we use the openly verifiable +107 and +138 hair counts and Endotext's "about two thirds" instead; average patient spend per transplant has no public ISHRS figure at all, despite the confident price statistics that circulate; and the newer market projections on research firms' own sites could not be opened for verification, so we quote only the projection published in Grand View Research's dated press release.